Skip to main content
. 2019 Dec 12;12:2655–2665. doi: 10.2147/DMSO.S233554

Table 4.

Comparison of 75 g OGTT and Glucose Metabolism Indicators During Pregnancy and After Delivery

NGT Group (n=104) AGT Group (n=74) P
Gestational period at diagnosis
 Fasting plasma glucose (mmol/L) 5.3 (5.1, 5.6) 5.6 (5.2, 6.1)a 0.033
 1 h plasma glucose (mmol/L) 9.4 (8.3, 10.5) 9.9 (8.6, 11.2) 0.120
 2 h plasma glucose (mmol/L) 8.2 (7.0, 9.2) 8.5 (7.6, 9.4) 0.301
 Fasting plasma insulin (μU/mL) 11.4 (8.3, 20.0) 13.5 (11.2, 17.9) 0.227
 1 h plasma insulin (μU/mL) 64.9 (44.5, 130.6) 111.8 (91.1, 139.9)a 0.038
 2 h plasma insulin (μU/mL) 82.1 (50.9, 141.8) 99.8 (67.7, 142.7) 0.621
 GA (%) 11.3 (9.7, 12.7) 11.5 (10.3, 13.2) 0.254
 HbA1c (%) 5.1 (4.9, 5.5) 5.4 (5.1, 5.9)b 0.007
 HOMA-IR 2.6 (2.0, 4.6) 3.3 (2.8, 4.2) 0.147
 HOMA-β 124.1 (82.0, 227.2) 135.8 (95.1, 203.7) 0.705
 Number of two or more abnormal values (n/%) 36 (34.6%) 32 (43.2%) 0.365
 Basal insulin treatment (n/%) 29 (27.9%) 43 (58.1%)b 0.001
 Meal insulin treatment (n/%) 15 (14.4%) 26 (35.1%)b 0.003
Screening period after delivery
 Fasting plasma glucose (mmol/L) 5.5 (5.1, 5.7) 6.2 (5.6, 6.7)b <0.001
 1 h plasma glucose (mmol/L) 8.4 (6.9, 10.2) 10.2 (8.9, 11.8)b <0.001
 2 h plasma glucose (mmol/L) 6.8 (6.2, 7.4) 8.5 (7.6, 9.1)b <0.001
 Fasting plasma insulin (μU/mL) 7.9 (5.3, 12.5) 9.9 (5.5, 15.1) 0.387
 1 h plasma insulin (μU/mL) 70.5 (38.1, 128.6) 66.0 (38.6, 97.4) 0.312
 2 h plasma insulin (μU/mL) 39.7 (26.8, 67.9) 56.6 (37.9, 86.9)a 0.031
 GA (%) 11.5 (10.6, 12.8) 11.9 (10.8, 13.5) 0.178
 HbA1c (%) 5.3 (5.0, 5.6) 5.6 (5.4, 6.1)b <0.001
 HOMA-IR 2.0 (1.3, 3.2) 2.6 (1.4, 4.2) 0.138
 HOMA-β 74.7 (61.9, 124.1) 77.3 (51.9, 110.9) 0.423

Notes: Data are presented as percentage (number of two or more abnormal values and insulin treatment), or median (interquartile range) (other glucose metabolism indicators). aP<0.05, bP<0.01 vs the NGT group.

Abbreviations: OGTT, oral glucose tolerance test; GA, glycated albumin; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β cell; NGT, normal glucose tolerance; AGT, abnormal glucose tolerance.